Heart, Lung and Circulation
Original Article| Volume 29, ISSUE 9, P1318-1327, September 2020

Download started.


Prognostic Value of Lactate Dehydrogenase for Mid-Term Mortality in Acute Decompensated Heart Failure: A Comparison to Established Biomarkers and Brain Natriuretic Peptide

Published:December 03, 2019DOI:


      Enzyme biomarkers–such as creatine phosphokinase, aspartate aminotransferase, and alanine aminotransferase–are associated with acute decompensated heart failure (ADHF) severity and, therefore, have a prognostic value in ADHF. However, the prognostic value of lactate dehydrogenase (LDH) is unclear. This study aimed to investigate the prognostic value of LDH in ADHF.


      This single-centre observational retrospective study enrolled 396 patients with ADHF between June 2014 and July 2016. The patients were categorised into groups based on the tertile values of serum LDH (LDH-low [<196 U/L], LDH-intermediate [196≤ LDH <239 U/L] and LDH-high [LDH ≥239 U/L]). Survival analysis for all-cause mortality was performed. This study also examined the ability of adding log-transformed LDH (LogLDH) on Get With The Guideline score, which is an established risk score to predict 90-day, 180-day and 365-day mortality using time-dependent receiver operating characteristic curves.


      During the follow-up (median, 204 days), 100 (25%) patients died. The LDH-intermediate and LDH-high groups had worse survival (LDH-low vs LDH-intermediate, log-rank p=0.019; LDH-low vs LDH-high, log-rank p<0.001). Log LDH improved the ability to predict 90-day, 180-day and 365-day all-cause mortality, which was statistically significant (90 days, area under curve [AUC] = 0.79, p=0.012; 180 days, AUC = 0.79, p=0.017; and 365 days, AUC = 0.79, p=0.025).


      Lactate dehydrogenase may be an important predictor of 90-day, 180-day and 365-day all-cause mortality in ADHF patients; however, further studies are needed to confirm these findings.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Arrigo M.
        • Parissis J.T.
        • Akiyama E.
        • Mebazaa A.
        Understanding acute heart failure: pathophysiology and diagnosis.
        Eur Heart J Suppl. 2016; 18: G11-G18
        • Frangogiannis N.G.
        Biomarkers: hopes and challenges in the path from discovery to clinical practice.
        Transl Res. 2012; 159: 197-204
        • Kemp M.
        • Donovan J.
        • Higham H.
        • Hooper J.
        Biochemical markers of myocardial injury.
        Br J Anaesth. 2004; 93: 63-73
        • Bodor G.S.
        Biochemical markers of myocardial damage.
        EJIFCC. 2016; 27: 95-111
        • Yilmaz A.
        • Yalta K.
        • Turgut O.O.
        • Yilmaz M.B.
        • Ozyol A.
        • Kendirlioglu O.
        • et al.
        Clinical importance of elevated CK-MB and troponin I levels in congestive heart failure.
        Adv Ther. 2006; 23: 1060-1067
        • Wettersten N.
        • Maisel A.
        Role of cardiac troponin levels in acute heart failure.
        Card Fail Rev. 2015; 1: 102-106
        • Hessel M.H.M.
        • Atsma D.E.
        • van der Valk E.J.M.
        • Bax W.H.
        • Schalij M.J.
        • van der Laarse A.
        Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation.
        Pflug Arch Eur J Phy. 2008; 455: 979-986
        • Lyon A.R.
        • Rees P.S.C.
        • Prasad S.
        • Poole-Wilson P.A.
        • Harding S.E.
        Stress (Takotsubo) cardiomyopathy - a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning.
        Nat Clin Pract Card. 2008; 5: 22-29
        • Samsky M.D.
        • Dunning A.
        • DeVore A.D.
        • Schulte P.J.
        • Starling R.C.
        • Tang W.H.W.
        • et al.
        Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
        Eur J Heart Fail. 2016; 18: 424-432
        • Biegus J.
        • Hillege H.L.
        • Postmus D.
        • Valente M.A.
        • Bloomfield D.M.
        • Cleland J.G.
        • et al.
        Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
        Eur J Heart Fail. 2016; 18: 830-839
        • Gray L.R.
        • Tompkins S.C.
        • Taylor E.B.
        Regulation of pyruvate metabolism and human disease.
        Cell Mol Life Sci. 2014; 71: 2577-2604
        • Macdonald R.P.
        • Simpson J.R.
        • Nossal E.
        Serum lactic dehydrogenase; a diagnostic aid in myocardial infarction.
        J Am Med Assoc. 1957; 165: 35-40
        • Glick Jr., J.H.
        Serum lactate dehydrogenase isoenzyme and total lactate dehydrogenase values in health and disease, and clinical evaluation of these tests by means of discriminant analysis.
        Am J Clin Pathol. 1969; 52: 320-328
        • Fonarow G.C.
        • Peacock W.F.
        • Phillips C.O.
        • Givertz M.M.
        • Lopatin M.
        • Committee A.S.A.
        • et al.
        Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
        J Am Coll Cardiol. 2007; 49: 1943-1950
        • McKee P.A.
        • Castelli W.P.
        • McNamara P.M.
        • Kannel W.B.
        The natural history of congestive heart failure: the Framingham study.
        N Engl J Med. 1971; 285: 1441-1446
        • Peterson P.N.
        • Rumsfeld J.S.
        • Liang L.
        • Albert N.M.
        • Hernandez A.F.
        • Peterson E.D.
        • et al.
        A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program.
        Circ Cardiovasc Qual Outcomes. 2010; 3: 25-32
        • Shiraishi Y.
        • Kohsaka S.
        • Abe T.
        • Mizuno A.
        • Goda A.
        • Izumi Y.
        • et al.
        Validation of the Get With The Guideline-Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level.
        Am Heart J. 2016; 171: 33-39
        • Zhang Z.
        Missing data exploration: highlighting graphical presentation of missing pattern.
        Ann Transl Med. 2015; 3: 356
        • Kanda Y.
        Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics.
        Bone Marrow Transpl. 2013; 48: 452-458
        • Heagerty P.J.
        • Lumley T.
        • Pepe M.S.
        Time-dependent ROC curves for censored survival data and a diagnostic marker.
        Biometrics. 2000; 56: 337-344
        • Rotenberg Z.
        • Weinberger I.
        • Davidson E.
        • Fuchs J.
        • Sperling O.
        • Agmon J.
        Atypical patterns of lactate dehydrogenase isoenzymes in acute myocardial infarction.
        Clin Chem. 1988; 34: 1096-1098
        • Piper C.
        • Horstkotte D.
        • Bock A.K.
        • Wudel E.
        • Schultheiss H.P.
        • Dorner A.
        Myocardial lactate dehydrogenase patterns in volume or pressure overloaded left ventricles.
        Eur J Heart Fail. 2002; 4: 587-591
        • Rotenberg Z.
        • Weinberger I.
        • Davidson E.
        • Fuchs J.
        • Sperling O.
        • Agmon J.
        Patterns of lactate dehydrogenase isoenzymes in serum of patients with acute pulmonary edema.
        Clin Chem. 1988; 34: 1882-1884
        • Alvarez A.M.
        • Mukherjee D.
        Liver abnormalities in cardiac diseases and heart failure.
        Int J Angiol. 2011; 20: 135-142
        • Kawase T.
        • Toyofuku M.
        • Higashihara T.
        • Okubo Y.
        • Takahashi L.
        • Kagawa Y.
        • et al.
        Validation of lactate level as a predictor of early mortality in acute decompensated heart failure patients who entered intensive care unit.
        J Cardiol. 2015; 65: 164-170
        • Weber M.
        • Hamm C.
        Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine.
        Heart. 2006; 92: 843-849
        • Meisenberg G.
        • Simmons W.
        Principles of Medical Biochemistry.
        3rd Edition. Saunders, Philadelphia, PA2011